Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-25T14:13:33.019Z Has data issue: false hasContentIssue false
  • English
  • Français

Three Generations of Bile Acid Sequestrants

Published online by Cambridge University Press:  15 February 2011

W. Harry Mandeville ,
William Braunlin ,
Pradeep Dhal ,
Amy Guo ,
Chad Huval ,
Karen Miller ,
John Petersen ,
Steven Polomoscanik ,
David Rosenbaum  and
Robert Sacchiero
...Show all authors
W. Harry Mandeville
Affiliation:
GelTex Pharmaceuticals, 9 Fourth Ave., Waltham, MA 02451
William Braunlin
Affiliation:
GelTex Pharmaceuticals, 9 Fourth Ave., Waltham, MA 02451
Pradeep Dhal
Affiliation:
GelTex Pharmaceuticals, 9 Fourth Ave., Waltham, MA 02451
Amy Guo
Affiliation:
GelTex Pharmaceuticals, 9 Fourth Ave., Waltham, MA 02451
Chad Huval
Affiliation:
GelTex Pharmaceuticals, 9 Fourth Ave., Waltham, MA 02451
Karen Miller
Affiliation:
GelTex Pharmaceuticals, 9 Fourth Ave., Waltham, MA 02451
John Petersen
Affiliation:
GelTex Pharmaceuticals, 9 Fourth Ave., Waltham, MA 02451
Steven Polomoscanik
Affiliation:
GelTex Pharmaceuticals, 9 Fourth Ave., Waltham, MA 02451
David Rosenbaum
Affiliation:
GelTex Pharmaceuticals, 9 Fourth Ave., Waltham, MA 02451
Robert Sacchiero
Affiliation:
GelTex Pharmaceuticals, 9 Fourth Ave., Waltham, MA 02451
James Ward
Affiliation:
GelTex Pharmaceuticals, 9 Fourth Ave., Waltham, MA 02451
S. Randall Holmes-Farley
Affiliation:
GelTex Pharmaceuticals, 9 Fourth Ave., Waltham, MA 02451
Get access

Abstract

Cholestyramine, the first bile acid sequestrant to be marketed, has been in use for over 20 years. Despite its low potency, requiring 16-24 g of polymer to achieve 20% LDL cholesterol reduction in hypercholesterolemic individuals, only one other sequestrant, colestipol, has come to market in the ensuing period. GelTex Pharmaceuticals has been involved for over six years in the discovery and development of new, more potent polymeric sequestrants. Two binding mechanisms are presented — one that operates via an aggregate binding structure and one that is effective via a defined site binding structure. These two binding mechanisms are compared and contrasted through bile acid binding isotherms. The best of these new sequestrants bind bile acids through a combination of hydrophobicity and ion exchange. Optimization and balancing of each of these interactions led us to more potent materials. The first of these, colesevelam hydrochloride is expected to be three to four times more potent than cholestyramine. A third generation product is still in research at GelTex. With another twofold increase in potency possible, single tablet therapy may become a reality.

Type
Research Article
Information
MRS Online Proceedings Library (OPL) , Volume 550: Symposium GG/HH/II – Biomedical Materials-Drug Delivery, Implants and Tissue Engr , 1998 , 3
Copyright
Copyright © Materials Research Society 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Bergen, S. S., Van Itallie, T. B., Tennent, D. M. and Sebrell, W. H., Proc. Soc. Exp. Biol., 102, pp. 676–679 (1959).Google Scholar
2. Stedronsky, E. R., Biochim. et Biophys. Acta, 1210, pp. 255–287 (1994) and references therein.Google Scholar
3. Newman, T. B. and Hully, S. B., J. Am. Med. Assoc., 275, pp. 55–60 (1996).Google Scholar
4. Myant, N. B. and Mitropoulos, K. A., J. Lipid Res., 18, pp. 135–153 (1977).Google Scholar
5. Dietschy, J. M. and Wilson, J. D., N. Engl. J. Med., 282, pp. 1128–38, 1179 (1970).Google Scholar
6. Miettinen, T. A., Adv. Lipid Res., 18, pp. 65–97 (1981).Google Scholar
7. Ostrow, J. D. in Hepatic Transport and Bile Secretion: Physiology and Pathophysiology: Tavolini, N. and Berk, P. D., Eds., Raven Press, New York, 1993, pp. 673–712 and references therein.Google Scholar
8. Buchwald, H., Moore, R. B., and Varco, R. L., Circulation, 49, pp. 1–37 (1974), Suppl. I.Google Scholar
9. Miettinen, T. A. and Lempinen, M., Eur. J. Clin. Invest., 7, pp. 509–514 (1977).Google Scholar
10. Benson, G. M., Haynes, C., Blanchard, S. and Ellis, D., J. Pharm Sci., 82, pp. 80–86 (1993).Google Scholar
11. Luner, P. E. and Amidon, G. L., J. Pharm. Sci., 82, pp. 311–318 (1993).Google Scholar
12. Andersen, E., Scand. J. Gastroenterol., 14, pp. 657–672 (1974).Google Scholar
13. Einarsson, K., Hellstrom, K. and , Kallner, Eur. J. Clin. Invest., 4, pp. 405–410 (1974).Google Scholar
14. Garbutt, J. T. and Kenney, J. T., J. Clin. Invest., 57, pp. 2781–2789 (1972).Google Scholar
15. Thistle, J. L. and Schoenfield, L. J., J. Lab. Clin. Med., 74, pp. 1020–1021 (1969).Google Scholar
16. Wood, P. D., Shioda, R., Estrich, D. L. and Splitter, S. D., Metabolism, 21, pp. 107–116 (1972).Google Scholar
17. Packard, C. J. and Sheperd, J., J. Lipid Res., 23, pp. 1081–1098 (1982).Google Scholar
18. Miettinen, T. A., Eur. J. Clin. Invest., 4, p. 365 (1974).Google Scholar
19. Miettinen, T. A. in Proc. Sixth Int. Congr. Pharmacol., Finnish Pharmacol. Soc., Helsinki, 1975, Vol. 4, pp. 149–158.Google Scholar
20. Zhu, X. X., Brown, G. R. and St. Pierre, L. E., J. Pharm. Sci., 81, pp. 65–69 (1992).Google Scholar
21. Hagerman, L. M., Cook, D. A. and Schneider, D. L., Proc. Soc. Exp. Biol. and Med., 199, pp. 248–253 (1972).Google Scholar
22. Leonard, D., Clas, S.-D. and brown, G. R., React. Polym., 20, pp. 131–140 (1993).Google Scholar
23. Luner, P. E. and Amidon, G. L., Pharm. Res., 9, pp. 670–676 (1992).Google Scholar
24. Polli, J. E. and Amidon, G. L., J. Pharm.. Sci., 84, pp. 55–61 (1995).Google Scholar
25. Hagerman, L. M., Julow, D. A. and Schneider, D. L., Proc. Soc. Exp. Biol. Med., 143, pp. 89–92 (1973).Google Scholar
26. Goddard, E. D., J. Amer. Oil Chem. Soc., 71, pp. 1–15 (1994) and references therein.Google Scholar
27. Lindman, B. and Thalberg, K., in Interactions of Surfactants with Polymers and Proteins, edited by Goddard, E. D. and Ananthapadmanabhan, K. P., CRC Press, Boca Raton, 1993, pp. 203–276.Google Scholar
28. Yim, C. T. and Brown, G. R., Langmuir, 10, pp. 4195–4202 (1994).Google Scholar
29. Mandeville, W. H., Holmes-Farley, S. R., Garigapati, V., Miller, K. L., Ward, J., Marchese, S., Ahearn, P. and Chen, X., poster presented at the Falk Conference, San Diego, CA, Sept. 29-30, (1994).Google Scholar
30. Wu, G., Brown, G. R., and St. Pierre, L. E., Langmuir, 12, pp. 466–471 (1996).Google Scholar
31. Cohen, D. E., Kaler, E. W. and Carey, M. C., Hepatology, 18, pp. 1522–1531 (1993).Google Scholar
32. Anthony, O. and Zana, R., Langmuir, 12, pp. 1967–1975 (1996).Google Scholar
33. Anthony, O. and Zana, R., Langmuir, 12, pp. 3590–3597 (1996).Google Scholar